In the article listed above, ERX was erroneously omitted from the duality of interest for Matthias H. Tschöp. The statement should have read “M.T.H. is a scientific advisor to Novo Nordisk and ERX.” The authors apologize for the error.
The online version of the article (https://doi.org/10.2337/db18-0146) has been updated to correct this omission.
© 2019 by the American Diabetes Association.
2019
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
